Organization
Syndax Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Syndax Pharmaceuticals, Inc.
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... WALTHAM, Mass. - Syndax Pharmaceuticals, Inc. ('Syndax,' the 'Company' or 'we') (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... WALTHAM, Mass. - Syndax Pharmaceuticals, Inc. ('Syndax,' the 'Company' or 'we') (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... WALTHAM - Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in ...
... Clinical Development for Pfizer. Briggs is currently Chief Executive Officer of Syndax Pharmaceuticals Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer ...
... Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in ...
... Mr. Shea currently serves as Chief Financial Officer and Treasurer of Syndax Pharmaceuticals, Inc., and previously served as a member of its board of directors ...
... WALTHAM, Mass - Syndax Pharmaceuticals, Inc. ('Syndax,' the 'Company' or 'we') (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax (Nasdaq: SNDX) announced today that it will release its second quarter 2017 financial ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company ...
... Currently Mr. Metzger serves as President and Chief Operating Officer of Syndax Pharmaceuticals, Inc.,a publicly traded oncology biopharmaceutical company. "I am extremely pleased to have ...
... WALTHAM, Mass., May 23, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX) announced today that it plans to offer and sell, subject ...
... Syndax Pharmaceuticals, Inc. has announced that it will present results from the melanoma cohort ...
... Syndax Pharmaceuticals, Inc. has reported that the ENCORE 601 non-small cell lung cancer, or ...
... WALTHAM, Mass., May 16, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company ...
... Gedeon Nyrt, Samyang Holdings Corp, Sanofi, Sanofi Pasteur SA, Sotio AS, Syndax Pharmaceuticals Inc, TapImmune Inc, Tyrogenex Inc, Vascular Biogenics Ltd, VentiRx Pharmaceuticals Inc, Verastem ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤